Search
About Wistar Research & Facilities Education & Training Technology Transfer Ways of Giving News & Information
         
 

Overview
Licensing Opportunities
Technologies
Research Tools
Patents
By Inventor
Material Transfers
Guidelines for Inventors
Contact Us
     
 

Monoclonal Antibody 452 Against Aminopeptidase N (CD13)

Inventor:  Meenhard Herlyn

Tech ID:    HM04RR

Description: Origin: Hybridoma cells producing MAb 452 were obtained after fusion of spleen cells derived from mice immunized with human dermal fibroblasts. Fusion was done with the SP2/0 variant of P3x63Ag8.

MAb 452 detects the 143 Kd aminopeptidase N that is present on monocytes, fibroblasts, and melanoma cells. Melanoma-associated aminopeptidase N is tightly associated with the extracellular matrix, and in vitro invasion assays indicate that aminopeptidase N acts in invasion by the digestion of a Mr 160,000 component in basement membranes.

Isotype: IgG1

Keywords: Industrial Relevance: Blood cell typing, tissue identification

Applications: Immunohistochemistry, cell identification, western blot, human frozen tissue sections.

Contact:

Meryle J. Melnicoff, Ph.D.
Director, Business Development The Wistar Institute
Phone: (215) 898-0049
melnicoff@wistar.org

 

 

 

Meenhard Herlyn, D.V.M.

 

Contact Us

Meryle Melnicoff, PhD
Director, Business Development

Christopher Harold Croft
Administrative Coordinator

 


  © 2007 The Wistar Institute | Terms of Use